Skip to main content
CRA Foundation Contact Us
Clinical Guidelines CRA Annual Scientific Meeting
0
News & Events
Members
Clinical Resources & Tools
Education & Career Advancements
Research & Grants
About Us
Clinical Guidelines CRA Annual Scientific Meeting
CRA Foundation Contact Us

Search Results

54 Results for:

Search
Clear Search
Refine Results
Displaying: 51-54 of 54 Results
Sort by
Chronic pain, Diclofenac and Cardiovascular Risk:  Management Algorithm
Algorithm for the Management of High Dose (150 mg daily) Diclofenac Usage in Chronic Pain Patients.
Nov 01, 2014
Cardiovascular Risk with Diclofenac:  Response to Health Canada
This metanalysis deals with the risks of cardiovascular and gastrointestinal events and deaths with the use of high-dose COX-2 inhibitors, diclofenac, and naproxen compared to placebo.. Reviewed by Therapeutics Committee in November 2021 and no changes made.
Nov 01, 2014
Canadian Recommendations for the Management of Spondyloarthropathy
The Canadian Rheumatology Association (CRA) and the Spondyloarthritis Research Consortium of Canada (SPARCC) have collaborated to update the recommendations for the management of spondyloarthritis (SpA)...
Apr 01, 2014
Canadian Recommendations for Management of RA
The CRA has developed 2011/2012 recommendations for the pharmacological management of RA that take into consideration Canada’s current healthcare system. The recommendations address treatment questions identified from a national needs assessment survey of Canadian rheumatology professionals and are published in […]
Aug 01, 2012